Abstract
Nasal continuous positive air pressure (nCPAP) treatment may favourably affect serum levels of advanced glycation end products (AGEs) in patients with obstructive sleep apnoea syndrome (OSAS). At baseline, OSAS patients had significantly higher levels of AGEs than controls. Six months after nCPAP initiation, AGEs decreased significantly. nCPAP treatment could lower AGEs in patients with OSAS.
Keywords: oxidative stress, advanced glycation, AGE, sleep apnoea, nasal CPAP
Full Text
The Full Text of this article is available as a PDF (469.5 KB).
Footnotes
There are no conflicts of interest in relation to the research presented.